Kohle-Compretten

Quick links to important sections

Kohle-Compretten

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Kohle-Compretten

Property Description
Active ingredient Activated charcoal (Medicinal charcoal, Carbo medicinalis)
Form Compressed tablet (designated as Compretten)
Pharmacological class Gastrointestinal adsorbent, Detoxifying agent
Common use Relief of minor intestinal discomfort, such as flatulence
Manufacturer/Origin Klinge Pharma GmbH (Associated with the German/Austrian market)

The Identity of Kohle-Compretten and its Pharmacological Class

Kohle-Compretten is a specific over-the-counter (OTC) pharmaceutical preparation commonly utilized across the German-speaking market. It is classified primarily as a gastrointestinal adsorbent and detoxifying agent, reflecting the substance's capacity for surface binding. The preparation is a single-ingredient product whose therapeutic identity is established by its sole active compound, Activated charcoal, which serves as an intestinal adsorbent within the digestive system.

Composition and Differentiating Form

The main active ingredient in this medicine is Activated charcoal, officially recognized under its pharmacopeial name, Medicinal charcoal (Carbo medicinalis). Kohle-Compretten is distinguished by its specific compressed tablet form—the "Compretten" designation—which provides a reliable, standardized dose that is easier to manage than bulk powder. The tablet is intended for oral administration, utilizing charcoal that is a derived, pharmacopeial grade substance, processed to maximize its porous surface area. The brand's focus on this compact tablet form contrasts with liquid or suspension products often used in emergency settings, positioning it for patient use in managing minor intestinal discomfort.

The General Purpose of an Intestinal Adsorbent

The general purpose of Kohle-Compretten is to help manage minor, non-specific intestinal discomfort by means of non-systemic adsorption. This mechanism allows the charcoal to physically bind various substances, including excessive gas and certain irritating compounds, onto its surface as it passes through the digestive tract. Activated charcoal acts as an adsorbent that helps prevent the absorption of substances by the intestine, providing non-chemical assistance for addressing common issues like flatulence and related digestive upset.

Regulatory References

  1. NIH/NCBI Bookshelf on Activated Charcoal

What side effects are possible with Kohle-Compretten?

Possible Side Effects and Safety Information

This section describes the officially documented adverse reactions and safety characteristics of medicinal charcoal, based strictly on government regulatory documents.

Since activated charcoal is not absorbed by the body, its documented safety profile is centered on effects within the gastrointestinal tract and risks related to its physical presence, rather than systemic complications.

Adverse Reaction Frequency Documented Adverse Reactions (Gastrointestinal)
Common Constipation; Black stools
Rare Slowing of the intestinal tract; Blocking of the intestinal tract
Not Known Gastrointestinal disturbances (including vomiting, diarrhea)

Serious Adverse Reactions and Safety Constraints

The most serious adverse reactions documented in regulatory sources relate to mechanical obstruction. These include gastrointestinal obstruction and faecal impaction, with the risk of obstruction specifically associated with the use of multiple-dose therapy. A critical safety risk documented is airway obstruction, which can occur if the substance is aspirated into the lungs.

Regulatory documents include specific safety constraints. The medicine is formally contraindicated in patients with an existing intestinal obstruction or those with an unprotected airway. The adsorbent nature of the compound also constitutes an important safety limitation: it can reduce the absorption of other oral medicines, requiring consideration for the timing of administration.

Population-Specific Safety Notes

The label notes that for unconscious patients, administration should only occur with an airway protective device in place, due to the high aspiration risk. Use during pregnancy and lactation is not contraindicated in official sources because the compound is not absorbed into the bloodstream.

Overdose and Emergency Response

Overdose with activated charcoal preparations, such as Kohle-Compretten, is characterized by non-systemic, physical complications within the gastrointestinal tract, as the substance itself is not absorbed into the body. The primary manifestations of overdose documented in regulatory labeling are Severe Constipation and Abdominal Distension, which result from the accumulation of the charcoal mass.

Regulator documents note that massive ingestion, particularly without adequate fluid intake, increases the risk of severe outcomes. The most serious formally documented complications arising from this physical accumulation include Gastrointestinal Obstruction and, in rare circumstances, Intestinal Perforation. A risk of Aspiration is also noted when the substance is administered as a liquid suspension to individuals with impaired consciousness.

Regulatory agencies mandate that Immediate Medical Attention must be sought if overdose symptoms include severe abdominal pain or the inability to pass stool, as these indicate a potential obstruction. Hospital Monitoring and Observation may be required to ensure the safe passage of the charcoal through the bowel. Management is strictly Symptomatic and Supportive Treatment; official labeling confirms that No Specific Antidote is Known for activated charcoal overdose. Special considerations exist for pediatric patients due to the heightened risk of aspiration and dehydration when administered in liquid form.

Therapeutic Uses of Kohle-Compretten

Easing Symptoms of Intestinal Gas and Bloating

This medication is commonly applied in contexts where patients experience symptoms related to physical discomfort such as excessive gas accumulation and abdominal distension. Activated charcoal is used to help address symptom clusters that may appear suddenly or fluctuate, contributing to improved comfort during periods of heightened symptoms by helping to moderate the burden of bloating and pressure.

Supportive Relief and Important Binding

This medicine is relevant in situations where supportive symptom management is appropriate, such as during episodes of acute, non-specific diarrhea or traveler's diarrhea. It offers symptomatic relief and supports patients during episodes of heightened discomfort related to loose or watery stools. Furthermore, in specialized clinical settings marked by heightened patient distress, this medicine provides important assistance for managing the potential effects of certain orally ingested poisons or drug over-ingestion. This supports managing heightened systemic burden, which is relevant in contexts involving temporary physiological imbalance.


Quick Fact: Relief for Acute Intestinal Upset Activated charcoal is generally used in areas where short-term symptom management is appropriate, assisting with maintaining functional stability during temporary physiological imbalance.

Eligibility and Restrictions for Use

Eligibility Map: Official Regulatory Information

This section outlines the eligibility criteria for using medicinal charcoal (Kohle-Compretten) strictly based on authoritative government regulatory documents, focusing on documented restrictions and contraindications.

Eligibility Scope Official Regulatory Statement
Populations for Whom Use is Allowed The general population, including adults, adolescents, and children over one year of age, provided none of the contraindications are present.
Populations for Whom Use is Contraindicated Individuals with a known hypersensitivity to medicinal charcoal or any excipients. Patients with an intestinal obstruction (bowel blockage) or high risk of gastrointestinal perforation/hemorrhage. Patients with diarrhea accompanied by fever.
Poisoning-Specific Exclusions Ingestion of corrosive substances (strong acids or alkalis) or petroleum distillates (e.g., gasoline, kerosene), as charcoal may be ineffective or hinder diagnostic procedures like endoscopy.
Airway/Consciousness Status Patients with an unprotected airway (e.g., depressed consciousness, high risk of seizure) due to the serious risk of aspiration pneumonitis.
Age-Related Eligibility Use is not established and generally not recommended for infants under one year of age.
Physiological Status The medicine is considered possibly safe for short-term use during pregnancy and breastfeeding, with professional consultation advised.

Official regulatory documents define eligibility by imposing strict contraindications where use is either unsafe or therapeutically inappropriate. These exclusions are primarily tied to airway protection, potential gastrointestinal complications, and the ineffectiveness of the charcoal against certain classes of poisons.

What should I know about interactions with other medicines?

The officially documented interaction profile for Kohle-Compretten (Medicinal charcoal) is based on a non-systemic pharmacokinetic interference. As a gastrointestinal adsorbent, the charcoal physically binds to, and significantly reduces the systemic absorption and bioavailability of, nearly all orally administered medicines. This action necessitates explicit restrictions to prevent therapeutic failure of other drugs.

To mitigate this reduction in drug exposure, regulatory authorities strictly mandate a timing separation rule. All other orally administered medicinal products must be separated from activated charcoal by at least two hours. This includes critical medicines such as cardiac glycosides (e.g., Digoxin) and the oral antidiabetic chlorpropamide, which have documented absorption reductions up to 90%.

Co-administration is formally contraindicated with specific agents, including medicines intended to induce vomiting (emetics) and certain oral antidotes, as the charcoal nullifies their intended effect. Pharmacodynamic conflicts also exist: co-use with agents that decrease intestinal motility, such as opioids or anticholinergics, requires caution due to an increased risk of intestinal complications. Additionally, the charcoal’s own binding effectiveness may be diminished by concurrent ingestion of food, milk, or other dairy products.

Mechanism of Action

Physical Adsorption and Non-Systemic Action

The mechanism of Activated charcoal is defined by physical adsorption, a process where gaseous molecules and chemical byproducts present in the gut adhere to the vast, porous surface area of the medicinal charcoal. This surface-based binding is non-covalent, meaning the charcoal's activity is strictly confined to the gastrointestinal lumen and bypasses systemic biological targets, such as receptors or enzymes.

Reducing Local Chemical and Gas Load

This physical sequestration initiates a mechanistic cascade that lowers the concentration of free, mobile chemical byproducts and gas molecules that might stimulate the intestinal wall. By lowering the overall chemical and gaseous load, the mechanism lessens the potential for mechanical distension of the gut tissue and minimizes the chemical stimulation of submucosal sensory neurons. The resulting physiological effect is a localized reduction in the excitability of sensory pathways originating from the intestine.

Mechanism Constraints

The action of the charcoal is entirely dependent on its binding capacity and the physicochemical properties of the target substance. The mechanism is constrained by a finite surface area, which can become saturated, and it is less effective against substances that are highly polar or very small. The mechanism is strictly confined to the contents of the GI tract because the charcoal is not absorbed, and consequently, it cannot influence molecules that have already undergone systemic absorption.

Dosage and Administration Information

Kohle-Compretten is intended for oral administration using the 250 mg compressed tablet form. The method of use, including dose and frequency, is determined by the purpose of the application.

For managing acute, non-specific intestinal upset, the standard adult regimen for those 14 years and older involves taking 2 to 4 tablets per dose, administered 3 to 5 times daily. Pediatric dosing for children up to 14 years is generally 1 to 2 tablets administered at the same frequency. All doses for intestinal upset are to be taken on an empty stomach. Self-treatment for this scenario is limited to a maximum of 3 days without consulting a health professional.

The tablets can be swallowed whole and unchewed with a sufficient amount of liquid, or they may be crushed and suspended in warm water—excluding milk—to form a slurry for ingestion. A fundamental restriction on use is the required time separation from all other orally administered medications to prevent potential interference with their absorption, a requirement based on the adsorbent nature of the medicinal charcoal. Furthermore, adequate replacement of fluid and electrolytes must be ensured, particularly in pediatric use.

In scenarios of acute poisoning or overdose, a standardized regimen does not apply. Instead, a higher, individualized dose is determined by a physician, and administration must occur under the supervision of specialists.

Recent Clinical Evidence

Activated charcoal, the active component of Kohle-Compretten, is known for its ability to bind to substances within the gastrointestinal (GI) tract through adsorption, preventing their absorption into the bloodstream.


Gastrointestinal Uses and Research

Research on activated charcoal for common digestive symptoms has yielded mixed findings and is generally considered limited when compared to its established use in clinical toxicology. Studies have primarily focused on two areas:

  • Intestinal Gas and Bloating: Some double-blind clinical trials have investigated the effect of activated charcoal on excessive intestinal gas production. Results from certain studies suggest that activated charcoal may be associated with a reduction in breath hydrogen levels—a measure of gas—and may help lessen symptoms of bloating and abdominal cramps. However, other studies have reported conflicting or inconclusive results regarding its consistent efficacy for these specific complaints.

  • Diarrhea: Evidence regarding the use of activated charcoal for general, non-infectious diarrhea remains limited. Research into its possible mechanism suggests that it may help bind to toxins or irritants within the gut that could contribute to diarrhea symptoms. High-quality, large-scale studies are still needed to clarify its role in the routine management of diarrhea.


Safety and Tolerability

While activated charcoal is not absorbed systemically, studies note that adverse events are possible, primarily affecting the GI system. Commonly reported side effects in clinical settings include constipation and black stools. In rare instances, administration has been linked to severe complications, such as bowel obstruction, particularly with large or multiple doses or in individuals with pre-existing motility disorders. Furthermore, due to its strong adsorptive properties, activated charcoal can reduce the absorption of other oral medications taken simultaneously, potentially lowering their effectiveness.

Frequently Asked Questions (FAQ)

Common questions about Kohle-Compretten (FAQ)


Q: Is Kohle-Compretten used for food poisoning as well as general diarrhea?

According to official government health authority documents, activated charcoal is used in the management of acute intoxications, which can include certain types of food poisoning. For severe poisoning, administration is required to occur under the supervision of a healthcare professional. For minor, non-specific intestinal upset, a self-treatment dose is typically indicated.


Q: What does 'accelerate excretion in the event of poisoning' mean in simple terms?

This mechanism, sometimes called enhanced elimination, occurs after some toxins or drugs have been absorbed into the bloodstream. These substances can recirculate back into the intestine. By continuously binding these recirculating substances in the gut, the charcoal prevents their reabsorption, thus speeding up their final removal from the body.


Q: Is Kohle-Compretten effective against diarrhea caused by viruses or bacteria?

The medicine's mechanism of action is designed to adsorb (bind) toxins and irritants within the gastrointestinal tract. Studies and official information indicate that its primary function is not to neutralize or directly eliminate the underlying pathogens, such as viruses or bacteria, that may be causing the infection.


Q: What happens if I use Kohle-Compretten for too many days in a row?

Regulatory documents state that self-treatment for acute intestinal upset should be limited to a maximum duration. The risk of rare but serious adverse effects, particularly gastrointestinal obstruction or severe constipation, may increase with prolonged or excessive use.


Q: Does taking this product cause dehydration?

Dehydration has been noted in official product information as a potential adverse effect, especially when using certain formulations or with insufficient fluid intake. Official guidance emphasizes the importance of taking the medicine with sufficient liquid and ensuring adequate fluid replacement is maintained.


Q: What is the ingredient 'medical charcoal' made from?

Medicinal charcoal, the active ingredient, is a form of carbon made from natural carbonaceous sources, such as wood, coconut shells, or peat. These raw materials are subjected to a special 'activation' process to create the vast, porous internal surface area necessary for the charcoal's binding function.


Q: Can Kohle-Compretten reduce the effectiveness of birth control pills?

Yes. Since activated charcoal can bind to and reduce the absorption of nearly all oral medications, official warnings confirm that taking it along with oral birth control pills can decrease the contraceptive's effectiveness. It is mandated that a time separation of at least two hours be maintained between the charcoal and your birth control pill.


Q: Does this medicine interact with alcohol?

Official health guidance indicates that concurrent consumption of alcohol may decrease the effectiveness of activated charcoal, particularly when the charcoal is used to bind toxins. The presence of alcohol can potentially interfere with the charcoal's primary binding action.


Q: Is it safe to take Kohle-Compretten with common over-the-counter pain relievers?

Activated charcoal is an indiscriminate binder that can significantly reduce the absorption of oral medicines, which includes many common pain relievers. It is required to strictly observe the two-hour time separation rule between taking the charcoal and taking any other oral medicine to mitigate this interaction.


Q: Can the charcoal bind vitamins or essential nutrients from food?

Yes. Activated charcoal's binding mechanism is not limited to toxins or drugs. Official safety information advises that it has the potential to bind with vitamins and other essential nutrients ingested through food, making them less available for absorption by the body.


Q: Does it interact with rehydration salts or electrolytes?

While the product is often taken alongside rehydration efforts, activated charcoal, especially in high doses, can potentially interfere with electrolyte levels. Official instructions emphasize that adequate replacement of fluid and electrolytes is necessary, particularly in children.


Q: Is the medicine still effective if a person has a condition that causes a slow-moving digestive tract?

Regulatory documents list intestinal obstruction as a contraindication, and caution is noted for conditions that slow the passage of food through the intestine. These conditions can increase the risk of serious complications, such as intestinal blockage. In such cases, consultation with a healthcare professional is noted in the official guidance.


Q: Is the medicine still effective if I vomit shortly after taking it for poisoning?

If the dose of charcoal is vomited, its effectiveness may be compromised because the charcoal may have been partially or completely expelled. In this scenario, official instructions direct the patient to contact a healthcare provider or a poison control center for further guidance.


Q: Is medical charcoal different from the charcoal used for cooking or BBQ?

Yes, medicinal charcoal is fundamentally different. It is manufactured and processed ('activated') to create a vast, porous internal structure, which gives it the necessary binding properties for therapeutic use. BBQ charcoal is not processed in this way and is not appropriate for medicinal use.


Q: Can Kohle-Compretten be used for general 'detox' or 'cleansing' purposes?

The regulatory-approved uses for this product are specifically for minor intestinal upset and the management of certain acute poisonings. Official scientific reviews indicate that there is currently no strong evidence to support its use for general 'detox' or 'cleansing' purposes.


Q: What are the known substances that medical charcoal does not bind?

The product is less effective against highly polar or small molecules. Official documents specify that it typically does not effectively bind or is not recommended for use against certain agents, including corrosive acids or bases, petroleum distillates, iron, lithium, and methanol.


Q: Why do some formulations of medical charcoal contain sugar or lactose?

These ingredients are typically inactive excipients added to help the manufacturing process. In tablets, they often act as fillers, binders, or stabilizers to help compress the charcoal powder into a solid, stable 'Compretten' form, or to improve taste.


Q: Is there ongoing research into new uses for medical charcoal?

Studies and clinical trials continue to explore other potential therapeutic applications for activated charcoal beyond toxicology and intestinal upset. Areas of ongoing research include its use in managing chronic kidney disease and as part of treatment protocols for other systemic conditions.

How should Kohle-Compretten be stored and disposed of?

How to Store and Dispose of Kohle-Compretten

The storage and disposal instructions for Kohle-Compretten (Medicinal charcoal 250 mg tablets) are defined by the official regulatory documents, ensuring product quality and adherence to environmental rules.

Official Storage Requirements

Requirement Regulatory Statement
Storage Conditions No special storage conditions are required for this product.
Temperature / Protection No explicit temperature, light, or humidity restrictions are mandated.
Packaging Store in the original PVC/PVdC-Aluminum blister packaging.
Shelf-Life The documented shelf-life is 5 years.
Child Safety Keep the medicine out of the sight and reach of children.

Disposal

Disposal instructions mandate that any unused or expired medicinal product or associated waste material must be eliminated in accordance with local requirements for pharmaceutical waste. General guidance advises against discarding medicines through household wastewater or sewage systems.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Kohle-Compretten found in:

A-Z Index: